L
Livio Tomasoni
Researcher at University of Milan
Publications - 36
Citations - 1579
Livio Tomasoni is an academic researcher from University of Milan. The author has contributed to research in topics: Population & Arthritis. The author has an hindex of 17, co-authored 36 publications receiving 1428 citations. Previous affiliations of Livio Tomasoni include University of Pavia & University of Naples Federico II.
Papers
More filters
Journal ArticleDOI
From endothelial dysfunction to atherosclerosis
Simona Sitia,Livio Tomasoni,Fabiola Atzeni,Giuseppe Ambrosio,C. Cordiano,Alberico L. Catapano,Simona Tramontana,Francesco Perticone,P. Naccarato,Paolo G. Camici,Eugenio Picano,Lauro Cortigiani,M. Bevilacqua,Laura Milazzo,Daniele Cusi,Cristina Barlassina,Piercarlo Sarzi-Puttini,Maurizio Turiel +17 more
TL;DR: The most important aspects of the pathogenesis and development of endothelial dysfunction are summarized, with particular attention to the role of traditional CV risk factors, the usefulness of vasoreactivity tests, and the future perspectives opened by genetic studies.
Journal ArticleDOI
Cardiovascular involvement in systemic autoimmune diseases
Simona Sitia,Fabiola Atzeni,Piercarlo Sarzi-Puttini,Vitantonio Di Bello,Livio Tomasoni,L. Delfino,Francesco Antonini-Canterin,Giovanni Di Salvo,Vito De Gennaro Colonna,Salvatore La Carrubba,Scipione Carerj,Maurizio Turiel +11 more
TL;DR: There are various means of detecting morphological cardiac damage: coronary angiography remains the gold standard for diagnosing coronary stenosis, but new, non invasive and more reliable methods have been introduced into clinical practice in order to detect subclinical microcirculation abnormalities.
Journal Article
Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule.
Vito De Gennaro Colonna,Mauro Bianchi,Valerio Pascale,P. Ferrario,Franca Morelli,Walter Pascale,Livio Tomasoni,Maurizio Turiel +7 more
TL;DR: The growing body of literature indicating that plasma ADMA levels have a predictive value for major cardiovascular events in prospective studies is discussed and an analysis is provided of the published data concerning the possibility to modulate plasmaADMA levels using drugs belonging to different pharmacological classes.
Journal ArticleDOI
Non-invasive assessment of coronary flow reserve and ADMA levels: a case–control study of early rheumatoid arthritis patients
Maurizio Turiel,Fabiola Atzeni,Livio Tomasoni,Simona de Portu,L. Delfino,Bruno Dino Bodini,Matteo Longhi,S. Sitia,Mauro Bianchi,P. Ferrario,Andrea Doria,Vito De Gennaro Colonna,Piercarlo Sarzi-Puttini +12 more
TL;DR: Whether ERA patients have more cardiovascular risk (endothelial dysfunction and coronary microvascular abnormalities), and whether any difference in intima-media thickness (IMT) and coronary flow reserve (CFR) levels between ERA and control groups can be explained by any change in ADMA levels between the groups.
Journal ArticleDOI
Effects of long-term disease-modifying antirheumatic drugs on endothelial function in patients with early rheumatoid arthritis.
Maurizio Turiel,Livio Tomasoni,Simona Sitia,S. Cicala,L. Gianturco,Cristian Ricci,Fabiola Atzeni,V. De Gennaro Colonna,M. Longhi,Piercarlo Sarzi-Puttini +9 more
TL;DR: It is shown that DMARDs, beyond the well known antiphlogistic effects, are able to improve coronary microcirculation without a direct effect on IMT and ADMA, clinical markers of atherosclerosis.